Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Experimental Hematology

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 7544737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular detection of tumor contamination in peripheral blood stem cell harvests.

  1994cited by this paper
• Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.

  1994cited by this paper
• Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

  1993cited by this paper
• High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

  1993cited by this paper
• Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.

  1993cited by this paper
• Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin.

  1992cited by this paper
• Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

  1992cited by this paper
• Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.

  1991cited by this paper
• A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow

  1991cited by this paper
• The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies.

  1991cited by this paper
• Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.

  1991cited by this paper
• Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology.

  1990cited by this paper
• Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.

  1990cited by this paper
• Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells.

  1990cited by this paper
• Autologous blood stem cell transplantation.

  1989cited by this paper
• GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

  1989cited by this paper
• Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.

  1989cited by this paper
• Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow

  1988cited by this paper
• Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia.

  1988cited by this paper
• Autologous stem cell transplantation using peripheral blood stem cells.

  1987cited by this paper
• Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

  1987cited by this paper
• Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.

  1986cited by this paper
• In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer.

  1986cited by this paper
• Autologous bone marrow transplantation in acute leukemia.

  1985cited by this paper
• Detection of micrometastases in patients with primary breast cancer.

  1983cited by this paper
• The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

  1982cited by this paper
• Increase in circulating stem cells following chemotherapy in man.

  1976cited by this paper

• DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer

  2025cites this paper
• Label‐Free Microfluidic Apheresis of Circulating Tumor Cell Clusters

  2024cites this paper
• Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspective

  2020cites this paper
• Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition

  2018cites this paper
• Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells

  2017cites this paper
• Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study

  2017cites this paper
• Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis.

  2017cites this paper
• The potential for liquid biopsies in the precision medical treatment of breast cancer

  2016cites this paper
• An integrated on-chip platform for negative enrichment of tumour cells.

  2016cites this paper
• Sample Preparation Methods Following CellSearch Approach Compatible of Single-Cell Whole-Genome Amplification: An Overview.

  2015cites this paper
• Biophotonics for blood analysis

  2015cites this paper
• Classification of blood cells and tumor cells using label‐free ultrasound and photoacoustics

  2015cites this paper
• Microfluidic, marker-free isolation of circulating tumor cells from blood samples

  2014cites this paper
• Circulating tumor cell detection using photoacoustic spectral methods

  2014cites this paper
• Carboxybetaine methacrylate-modified nylon surface for circulating tumor cell capture.

  2014cites this paper
• Dynamic Changes in Numbers and Properties of Circulating Tumor Cells and Their Potential Applications

  2014cites this paper
• ‘Go with the flow ’: A review of methods and advancements in blood flow imaging

  2013cites this paper
• Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR.

  2013cites this paper
• Advances in Blood Flow Imaging

  2013cites this paper
• Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR.

  2012cites this paper
• DETECTION OF MINIMAL RESIDUAL DISEASE IN BREAST CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND STEM CELL RESCUE by Ada

  2012cites this paper
• A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire

  2012cites this paper
• Molecular to Microscale Technologies for Immunoaffinity Based Tumor Cell Capture in Microchannels

  2012cites this paper
• Circulating Tumor Cells in Lung Cancer

  2011cites this paper
• Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications

  2011cites this paper
• Circulating tumor cells : approaches to isolation and characterization

  2011cites this paper
• Circulating tumor cells: approaches to isolation and characterization

  2011cites this paper
• A novel auto-adhere method for the capture and analysis of live circulation tumor cells

  2010cites this paper
• Circulating tumour cells in clinical practice: Methods of detection and possible characterization.

  2010cites this paper
• Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting

  2009cites this paper
• Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic

  2009cites this paper
• Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry

  2009cites this paper
• Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.

  2009cites this paper
• Nachweis von disseminierten Tumorzellen im Knochenmark bei Patientinnen mit primärem, nicht- metastasiertem Mammakarzinom und Charakterisierung der Her-2/neu- Expression über immunzytochemische Doppelfärbungen

  2006cites this paper
• Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples.

  2005cites this paper
• Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry

  2005cites this paper
• An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.

  2005cites this paper
• Original Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer

  2005cites this paper
• Circulating tumour cells in breast cancer.

  2004cites this paper
• USEFUL PRODUCTS FROM ALGAL PHOTOSYNTHESIS

  2004cites this paper
• Immunomagnetic Tumor Cell Enrichment Is Promising in Detecting Circulating Breast Cancer Cells

  2003cites this paper
• [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects].

  2003cites this paper
• Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

  2003cites this paper
• Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy

  2003cites this paper
• Tumor Cell Dissemination in Solid Tumors: Clinical Usefulness of Diagnostic Approaches, Prognostic Significance, and Therapeutical Options

  2003cites this paper
• Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?

  2002cites this paper
• Detection of Epithelial Cells in Hematopoietic Organs of Patients with Breast Cancer

  2001cites this paper
• Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients.

  2001cites this paper
• The Expression of G 250 / MN / CA 9 Antigen by Flow Cytometry : Its Possible Implication for Detection of Micrometastatic Renal Cancer Cells 1

  2001cites this paper
• The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.

  2001cites this paper
• Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.

  2001cites this paper
• Micrometástasis en tumores sólidos: ¿Qué son y qué significa su detección por métodos de inmunohistoquímica?

  2000cites this paper
• Eradication of Multiple Myeloma and Breast Cancer Cells by TH9402-mediated Photodynamic Therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem Cell Transplants¶

  2000cites this paper
• Flow cytometric analysis of antigen expression in malignant and normal renal cells.

  2000cites this paper
• Bone marrow “micrometastases” of epithelial tumors: detection and clinical relevance

  2000cites this paper
• MicrometÆstasis en tumores sÛlidos: ¿quØ son y quØ significa su detecciÛn por mØtodos de inmunohistoquÌmica?

  2000cites this paper
• The use of the CELLection kit in the isolation of carcinoma cells from mononuclear cell suspensions.

  2000cites this paper
• Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial

  2000cites this paper
• Eradication of Multiple Myeloma and Breast Cancer Cells by TH9402‐mediated Photodynamic Therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem Cell Transplants ¶

  2000cites this paper
• Breast Tumor Contamination of Peripheral Blood Stem Cell Harvests: Increased Sensitivity of Detection Using Immunomagnetic Enrichment

  2000cites this paper
• Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients.

  1999cites this paper
• Positive selection of autologous peripheral blood stem cells.

  1999cites this paper
• Detection and clinical importance of micrometastatic disease.

  1999cites this paper
• Use of Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) for Carcinoembryonic Antigen, Cytokeratin 19, and Maspin in the Detection of Tumor Cells in Leukapheresis Products from Patients with Breast Cancer: Comparison with Immunocytochemistry

  1999cites this paper
• Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumors.

  1999cites this paper
• Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.

  1999cites this paper
• Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single‐centre matched‐pair analysis

  1999cites this paper
• Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

  1999cites this paper
• Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood.

  1999cites this paper
• Evaluation of the silicon phthalocyanine pc 4 for photodynamic bone marrow purging.

  1998cites this paper
• Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions.

  1998cites this paper
• Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.

  1998cites this paper
• In Vitro Manipulation of Peripheral Blood Progenitor Cell Collections

  1998cites this paper
• Haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cell rescue: the effects of the mobilization regimen and post-transplant growth factors.

  1998cites this paper
• Haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cell rescue: the effects of the mobilization regimen and post-transplant growth factors.

  1998cites this paper
• Isolation of blood‐borne epithelium‐derived c‐erbB‐2 oncoprotein‐positive clustered cells from the peripheral blood of breast cancer patients

  1998cites this paper
• Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA

  1998cites this paper
• Seperation of G-CSF-mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34+ cells but no loss of primitive haemopoietic progenitors Kwekkeboom,

  1997cites this paper
• U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.

  1997cites this paper
• Peripheral blood mobilization of hematopoietic stem cells: cytokine-mediated regulation of adhesive interactions within the hematopoietic microenvironment.

  1997cites this paper
• Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.

  1997cites this paper
• Separation of G‐CSF‐mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34+ cells but no loss of primitive haemopoietic progenitors

  1997cites this paper
• Immunocytochemical Detection of Breast Cancer Cells: A Comparison of Three Attachment Factors

  1997cites this paper
• G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia

  1997cites this paper
• The biology and clinical uses of blood stem cells.

  1997cites this paper
• A Novel Gene Therapy Strategy for Elimination of Prostate Carcinoma Cells from Human Bone Marrow

  1997cites this paper
• Stem cell manipulation: why and how performing peripheral blood progenitor cell purging.

  1997cites this paper
• Purging: the separation of normal from malignant cells for autologous transplantation

  1996cites this paper
• Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.

  1996cites this paper
• Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.

  1996cites this paper
• WHAT TRIGGERS THE INITIATIVE OF DEVELOPMENTS IN TRANSFUSION MEDICINE: ADVANCES IN EX VIVO HAEMATOPOIETIC CELL THERAPY AND NEXT GENERATION TRANSFUSION PRODUCTS.

  1996cites this paper